FDA Aims To Reduce 510(k) Review Times With New Submission Acceptance Process

Draft guidance outlines criteria that 510(k) submissions must meet before the agency begins its substantive review.

FDA is proposing new acceptance criteria for 510(k) submissions with the goal of improving overall review times and enhancing the quality of submissions.

A draft guidance released Aug. 10, “Refuse to Accept Policy for 510(k)s,” modifies guidances from 1993 and 1994 by adding a quick, early-review process for FDA to determine...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation